Bangrong Cao

6PUBLICATIONS
19CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 29, 2024
Image-Based Assessment of Obesity and Metabolic Pathway Alterations in Non-small Cell Lung Cancer.

Xing Wei, Jieke Liu, Bangrong Cao

|Aug 20, 2024
Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.

Lei Wu, Baisen Li, Gang Wan

|Apr 04, 2024
Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial.

Wei Dai, Yaqin Wang, Jia Liao

|Nov 29, 2023
Tumor-infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape.

Liping Zhang, Qiaoying Zhu, Qi Zhao

|Jan 07, 2022
Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.

Wei Dai, Wenhong Feng, Yuanqiang Zhang

|Mar 22, 2021
Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.

Shiqi Ma, Lu Zhang, Yuan Ren

Pageof 1

Frequent Collaborators

3 joint publications

Xing Wei

3 joint publications

Qiuling Shi

3 joint publications

Qifeng Wang

2 joint publications

Wei Dai